Summary

Implantable Port Market Research Report By Material Type (Silicone, Polyurethane, Titanium), By Application (Chemotherapy, Antibiotic Therapy, Total Parenteral Nutrition, Blood Transfusion), By Insertion Method (Surgical Insertion, Percutaneous Insertion) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) Forecast to 2035
Overview of the Market
According to MRFR research, the Implantable Port Market Size was projected at 2024 USD 3,290.28 Million. The Implantable Port Market Industry is projected to develop at a CAGR (growth rate) of 6.21% over the forecast period (2025 - 2035).
Rising prevalence of chronic diseases drive the Implantable Port Market, which in turn increases the need for long-term intravenous access options. Implantable ports are becoming more popular as healthcare practitioners concentrate on improving patient comfort and treatment efficacy. Outpatient and home healthcare environments are expanding, which also drives demand as these facilities need consistent, efficient ways to deliver medication. Improvements in medical technology also guarantee safer, more durable implants, hence driving market expansion even more. Market possibilities include the creation of materials encouraging biocompatibility and reducing infection risk, therefore opening the path for more creative implantable port designs. Increasing patient-centric care focus opens up possibilities for including digital health technologies—such as remote monitoring systems—to enhance patient management. Increasing knowledge among healthcare professionals about the advantages of implantable ports can help to boost market penetration as well, particularly in underdeveloped areas where such technology is still being accepted. Recent trends show a move toward minimally invasive treatments, which would make implantable ports more appealing to both patients and doctors. Manufacturers and doctors working together are more common as they seek to enhance the design and use of these gadgets.

Insights on Market Segments
The worldwide implanted port market has been divided into silicone, polyurethane, and titanium depending on material kind.
The global implantable port market has been divided into chemotherapy, antibiotic therapy, complete parenteral nutrition, and blood transfusion depending on application.
The worldwide implantable port market has been divided into surgical insertion and percutaneous insertion depending on insertion technique. The fastest expanding sector during the forecast period, the surgical insertion segment had the largest market in 2024.

Regional Knowledge

The worldwide implantable port market has been divided into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa depending on the area. In 2024, North America had the biggest market share and is projected to reach USD 2,416.61 million by 2035. On the other hand, Asia-Pacific is expected to expand at the fastest CAGR of 8.32% throughout the forecast period.
With a predicted CAGR of 5.20% throughout the forecast period, the North America implantable port market made USD 1,382.75 million in 2024. North America is also divided into the US and Canada.
With a predicted CAGR of 6.41% throughout the projection period, the Europe implantable port market was USD 972.35 million in 2024. Europe is divided more into Rest of Europe, Russia, Spain, Italy, France, UK, and Germany.

Key Players
Major Companies in the Implantable Port Market Include Easton Medical, Baxter International, Zyga Technology, Terumo, Apex Medical Technologies, Medtronic, Boston Scientific, Cook Medical, AngioDynamics, Kirwan Surgical Products, Smiths Medical, Nitinol Devices Corporation, C R Bard, Stryker, and Halyard Health.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ............................................................................................................... 19
1.1 OVERVIEW .................................................................................................................................................................... 19
1.2 MARKET ATTRACTIVENESS ANALYSIS ........................................................................................................... 20
1.3 GLOBAL IMPLANTABLE PORT MARKET, BY MATERIAL TYPE ................................................................ 21
1.4 GLOBAL IMPLANTABLE PORT MARKET, BY APPLICATION ...................................................................... 22
1.5 GLOBAL IMPLANTABLE PORT MARKET, BY END USER .............................................................................. 23
1.6 GLOBAL IMPLANTABLE PORT MARKET, BY INSERTION METHOD ........................................................ 24
1.7 GLOBAL IMPLANTABLE PORT MARKET, BY REGION ................................................................................... 25
2 MARKET INTRODUCTION ............................................................................................................ 27
2.1 DEFINITION .................................................................................................................................................................. 27
2.2 SCOPE OF THE STUDY .............................................................................................................................................. 27
2.3 RESEARCH OBJECTIVE ............................................................................................................................................ 27
2.4 MARKET STRUCTURE .............................................................................................................................................. 27
3 RESEARCH METHODOLOGY ...................................................................................................... 28
3.1 OVERVIEW .................................................................................................................................................................... 28
3.2 DATA FLOW .................................................................................................................................................................. 30
3.2.1 Data Mining Process ....................................................................................................................................... 30
3.3 PURCHASED DATABASE: ......................................................................................................................................... 31
3.4 SECONDARY SOURCES: ............................................................................................................................................ 32
3.4.1 Secondary Research Data Flow: ....................................................................................................................... 33
3.5 PRIMARY RESEARCH: ............................................................................................................................................... 34
3.5.1 Primary Research Data Flow: .......................................................................................................................... 35
3.5.2 Primary Research: Number of Interviews conducted ........................................................................................ 36
3.5.3 Primary Research: Regional Coverage ............................................................................................................. 36
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................................................................................... 37
3.6.1 Revenue Analysis Approach ............................................................................................................................ 37
3.7 DATA FORECASTING................................................................................................................................................. 38
3.7.1 Data forecasting Type ..................................................................................................................................... 38
3.8 DATA MODELING ........................................................................................................................................................ 39
3.8.1 Microeconomic Factor Analysis: ...................................................................................................................... 39
3.8.2 Data modeling: ............................................................................................................................................... 40
3.9 TEAMS AND ANALYST CONTRIBUTION ........................................................................................................... 42
4 MARKET DYNAMICS .................................................................................................................... 44
4.1 INTRODUCTION ........................................................................................................................................................... 44
4.2 DRIVERS ......................................................................................................................................................................... 44
4.2.1 Increasing Incidences of Chronic Diseases across the globe............................................................................. 44
4.2.2 Technological Advancements .......................................................................................................................... 45
4.2.3 Better Healthcare Access ................................................................................................................................ 46
4.3 RESTRAINTS ................................................................................................................................................................ 47
4.3.1 High Cost of Implantation ............................................................................................................................... 47
4.3.2 Surgical Risks ................................................................................................................................................. 47
4.4 OPPORTUNITY ............................................................................................................................................................. 48
4.4.1 Expansion in Emerging Markets ....................................................................................................................... 48
4.4.2 Growing Aging Population ............................................................................................................................... 48
5 MARKET FACTOR ANALYSIS ...................................................................................................... 49
5.1 VALUE CHAIN ANALYSIS ....................................................................................................................................... 49
5.1.1 R&D ............................................................................................................................................................... 49
5.1.2 Manufacturing ................................................................................................................................................ 49
5.1.3 Marketing and Distribution & Channel .............................................................................................................. 49
5.1.4 Post-market Surveillance ................................................................................................................................ 50
5.2 PORTER'S FIVE FORCES MODEL ........................................................................................................................... 50
5.2.1 Threat of New Entrants ................................................................................................................................... 51
5.2.2 Bargaining Power of Suppliers ......................................................................................................................... 51
5.2.3 Threat of Substitutes ...................................................................................................................................... 52
5.2.4 Bargaining Power of Buyers ............................................................................................................................ 52
5.2.5 Intensity of Rivalry .......................................................................................................................................... 52
5.3 IMPACT OF COVID-19 ON THE GLOBAL IMPLANTABLE PORT MARKET ............................................... 53
6 GLOBAL IMPLANTABLE PORT MARKET, BY MATERIAL TYPE ................................................. 55
6.1 OVERVIEW .................................................................................................................................................................... 55
6.2 SILICONE ........................................................................................................................................................................ 57
6.3 POLYURETHANE ........................................................................................................................................................ 58
6.4 TITANIUM ..................................................................................................................................................................... 58
7 GLOBAL IMPLANTABLE PORT MARKET, BY APPLICATION ...................................................... 59
7.1 OVERVIEW .................................................................................................................................................................... 59
7.2 CHEMOTHERAPY ....................................................................................................................................................... 61
7.3 ANTIBIOTIC THERAPY ............................................................................................................................................. 62
7.4 TOTAL PARENTERAL NUTRITION ...................................................................................................................... 62
7.5 BLOOD TRANSFUSION .............................................................................................................................................. 63
8 GLOBAL IMPLANTABLE PORT MARKET, BY END USER ........................................................... 64
8.1 OVERVIEW .................................................................................................................................................................... 64
8.2 HOSPITALS ................................................................................................................................................................... 66
8.3 AMBULATORY SURGICAL CENTERS ................................................................................................................... 67
8.4 SPECIALIZED CLINICS ............................................................................................................................................... 67
9 GLOBAL IMPLANTABLE PORT MARKET, BY INSERTION METHOD ......................................... 68
9.1 OVERVIEW .................................................................................................................................................................... 68
9.2 SURGICAL INSERTION .............................................................................................................................................. 70
9.3 PERCUTANEOUS INSERTION ................................................................................................................................. 71
10 GLOBAL IMPLANTABLE PORT MARKET, BY REGION ............................................................... 72
10.1 OVERVIEW .................................................................................................................................................................... 72
10.2 NORTH AMERICA ....................................................................................................................................................... 74
10.2.1 US.................................................................................................................................................................. 77
10.2.2 CANADA ........................................................................................................................................................ 78
10.3 EUROPE .......................................................................................................................................................................... 80
10.3.1 GERMANY ...................................................................................................................................................... 83
10.3.2 FRANCE ......................................................................................................................................................... 84
10.3.3 UK ................................................................................................................................................................. 86
10.3.4 ITALY ............................................................................................................................................................. 88
10.3.5 SPAIN ............................................................................................................................................................ 90
10.3.6 RUSSIA .......................................................................................................................................................... 92
10.3.7 REST OF EUROPE ............................................................................................................................................ 94
10.4 ASIA-PACIFIC ............................................................................................................................................................... 96
10.4.1 CHINA ............................................................................................................................................................ 99
10.4.2 INDIA ............................................................................................................................................................. 100
10.4.3 JAPAN ........................................................................................................................................................... 102
10.4.4 SOUTH KOREA ................................................................................................................................................ 103
10.4.5 MALAYSIA ..................................................................................................................................................... 104
10.4.6 THAILAND ...................................................................................................................................................... 106
10.4.7 INDONESIA ..................................................................................................................................................... 107
10.4.8 REST OF ASIA-PACIFIC ................................................................................................................................... 108
10.5 SOUTH AMERICA ....................................................................................................................................................... 110
10.5.1 BRAZIL ........................................................................................................................................................... 113
10.5.2 MEXICO ......................................................................................................................................................... 114
10.5.3 ARGENTINA ................................................................................................................................................... 116
10.5.4 REST OF SOUTH AMERICA .............................................................................................................................. 117
10.6 MIDDLE EAST AND AFRICA .................................................................................................................................... 119
10.6.1 GCC COUNTRIES............................................................................................................................................. 122
10.6.2 SOUTH AFRICA ............................................................................................................................................... 123
10.6.3 REST OF MIDDLE EAST AND AFRICA ................................................................................................................ 125
11 COMPETITIVE LANDSCAPE ........................................................................................................ 128
11.1 INTRODUCTION ........................................................................................................................................................... 128
11.2 COMPANY MARKET SHARE ANALYSIS, 2024 (VALUE) ............................................................................... 128
11.3 COMPETITOR DASHBOARD..................................................................................................................................... 129
11.4 PUBLIC PLAYERS STOCK SUMMARY ................................................................................................................. 130
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL .............................................................................. 130
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ............................................................................................ 130
11.6.1 DONATION ..................................................................................................................................................... 130
11.6.2 AGREEMENT .................................................................................................................................................. 131
12 COMPANY PROFILES .................................................................................................................. 132
12.1 ANGIODYNAMICS, INC. ............................................................................................................................................. 132
12.1.1 COMPANY OVERVIEW ..................................................................................................................................... 132
12.1.2 FINANCIAL OVERVIEW .................................................................................................................................... 133
12.1.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 134
12.1.4 KEY DEVELOPMENTS ...................................................................................................................................... 135
12.1.5 SWOT ANALYSIS ............................................................................................................................................ 136
12.1.6 KEY STRATEGIES ............................................................................................................................................ 136
12.2 B. BRAUN MELSUNGEN AG .................................................................................................................................... 137
12.2.1 COMPANY OVERVIEW ..................................................................................................................................... 137
12.2.2 FINANCIAL OVERVIEW .................................................................................................................................... 138
12.2.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 138
12.2.4 KEY DEVELOPMENTS ...................................................................................................................................... 139
12.2.5 SWOT ANALYSIS ............................................................................................................................................ 139
12.2.6 KEY STRATEGIES ............................................................................................................................................ 139
12.3 BECTON, DICKINSON AND COMPANY (BD) ....................................................................................................... 140
12.3.1 COMPANY OVERVIEW ..................................................................................................................................... 140
12.3.2 FINANCIAL OVERVIEW .................................................................................................................................... 141
12.3.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 141
12.3.4 KEY DEVELOPMENTS ...................................................................................................................................... 142
12.3.5 SWOT ANALYSIS ............................................................................................................................................ 142
12.3.6 KEY STRATEGIES ............................................................................................................................................ 143
12.4 COOK MEDICAL LLC ................................................................................................................................................... 144
12.4.1 COMPANY OVERVIEW ..................................................................................................................................... 144
12.4.2 FINANCIAL OVERVIEW .................................................................................................................................... 144
12.4.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 145
12.4.4 KEY DEVELOPMENTS ...................................................................................................................................... 145
12.4.5 SWOT ANALYSIS ............................................................................................................................................ 145
12.4.6 KEY STRATEGIES ............................................................................................................................................ 146
12.5 DISTRICLASS MEDICAL SA ..................................................................................................................................... 147
12.5.1 COMPANY OVERVIEW ..................................................................................................................................... 147
12.5.2 FINANCIAL OVERVIEW .................................................................................................................................... 147
12.5.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 147
12.5.4 KEY DEVELOPMENTS ...................................................................................................................................... 147
12.5.5 SWOT ANALYSIS ............................................................................................................................................ 148
12.5.6 KEY STRATEGIES ............................................................................................................................................ 148
12.6 VYGON ............................................................................................................................................................................ 149
12.6.1 COMPANY OVERVIEW ..................................................................................................................................... 149
12.6.2 FINANCIAL OVERVIEW .................................................................................................................................... 150
12.6.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 150
12.6.4 KEY DEVELOPMENTS ...................................................................................................................................... 151
12.6.5 SWOT ANALYSIS ............................................................................................................................................ 151
12.6.6 KEY STRATEGIES ............................................................................................................................................ 152
12.7 SILMAG AG.................................................................................................................................................................... 153
12.7.1 COMPANY OVERVIEW ..................................................................................................................................... 153
12.7.2 FINANCIAL OVERVIEW .................................................................................................................................... 153
12.7.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 153
12.7.4 KEY DEVELOPMENTS ...................................................................................................................................... 153
12.7.5 SWOT ANALYSIS ............................................................................................................................................ 154
12.7.6 KEY STRATEGIES ............................................................................................................................................ 154
12.8 POLY MEDICURE LTD ................................................................................................................................................ 155
12.8.1 COMPANY OVERVIEW ..................................................................................................................................... 155
12.8.2 FINANCIAL OVERVIEW .................................................................................................................................... 156
12.8.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 156
12.8.4 KEY DEVELOPMENTS ...................................................................................................................................... 158
12.8.5 SWOT ANALYSIS ............................................................................................................................................ 158
12.8.6 KEY STRATEGIES ............................................................................................................................................ 159
12.9 PAKUMEDMEDICAL PRODUCTS GMBH ............................................................................................................. 160
12.9.1 COMPANY OVERVIEW ..................................................................................................................................... 160
12.9.2 FINANCIAL OVERVIEW .................................................................................................................................... 160
12.9.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 161
12.9.4 KEY DEVELOPMENTS ...................................................................................................................................... 161
12.9.5 SWOT ANALYSIS ............................................................................................................................................ 162
12.9.6 KEY STRATEGIES ............................................................................................................................................ 162
12.10 SOPHYSA ....................................................................................................................................................................... 163
12.10.1 COMPANY OVERVIEW ..................................................................................................................................... 163
12.10.2 FINANCIAL OVERVIEW .................................................................................................................................... 163
12.10.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 164
12.10.4 KEY DEVELOPMENTS ...................................................................................................................................... 164
12.10.5 SWOT ANALYSIS ............................................................................................................................................ 164
12.10.6 KEY STRATEGIES ............................................................................................................................................ 165
13 DATA CITATIONS ......................................................................................................................... 166